Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 by Company, Type and Application, Forecast to 2025

  • receipt Report ID : 117651
  • calendar_today Published On: Sep, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Induced Pluripotent Stem Cells (iPSCs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Induced Pluripotent Stem Cells (iPSCs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 129.1 million by 2025, from USD 83 million in 2019.

Market segmentation

Induced Pluripotent Stem Cells (iPSCs) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Induced Pluripotent Stem Cells (iPSCs) market has been segmented into Human iPSCs, Mouse iPSCs, etc.

Breakdown by Application, Induced Pluripotent Stem Cells (iPSCs) has been segmented into Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, Others, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Induced Pluripotent Stem Cells (iPSCs) market presented in the report. This section sheds light on the sales growth of different regional and country-level Induced Pluripotent Stem Cells (iPSCs) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Induced Pluripotent Stem Cells (iPSCs) market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Induced Pluripotent Stem Cells (iPSCs) Market Share Analysis

Induced Pluripotent Stem Cells (iPSCs) competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Induced Pluripotent Stem Cells (iPSCs) revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Induced Pluripotent Stem Cells (iPSCs) revenue and market share for each player covered in this report.

The major players covered in Induced Pluripotent Stem Cells (iPSCs) are: Fujifilm Holding Corporation (CDI), ReproCELL, Astellas Pharma Inc, Ncardia, Cell Inspire Biotechnology, Sumitomo Dainippon Pharma, Pluricell Biotech, Fate Therapeutics, Inc, etc. Among other players domestic and global, Induced Pluripotent Stem Cells (iPSCs) market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

Fujifilm Holding Corporation (CDI)

ReproCELL

Astellas Pharma Inc

Ncardia

Cell Inspire Biotechnology

Sumitomo Dainippon Pharma

Pluricell Biotech

Fate Therapeutics, Inc

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

Human iPSCs

Mouse iPSCs

Market segment by Application, can be divided into

Academic Research

Drug Development and Discovery

Toxicity Screening

Regenerative Medicine

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Induced Pluripotent Stem Cells (iPSCs)

1.2 Classification of Induced Pluripotent Stem Cells (iPSCs) by Type

1.2.1 Overview: Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type in 2019

1.2.3 Human iPSCs

1.2.4 Mouse iPSCs

1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market by Application

1.3.1 Overview: Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Academic Research

1.3.3 Drug Development and Discovery

1.3.4 Toxicity Screening

1.3.5 Regenerative Medicine

1.3.6 Others

1.4 Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

1.5 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2015-2020)

1.7 Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)

1.7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)

1.7.3 Asia Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)

1.7.4 South America Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Status and Prospect (2015-2025)

2 Company Profiles

2.1 Fujifilm Holding Corporation (CDI)

2.1.1 Fujifilm Holding Corporation (CDI) Details

2.1.2 Fujifilm Holding Corporation (CDI) Major Business

2.1.3 Fujifilm Holding Corporation (CDI) SWOT Analysis

2.1.4 Fujifilm Holding Corporation (CDI) Product and Services

2.1.5 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.2 ReproCELL

2.2.1 ReproCELL Details

2.2.2 ReproCELL Major Business

2.2.3 ReproCELL SWOT Analysis

2.2.4 ReproCELL Product and Services

2.2.5 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.3 Astellas Pharma Inc

2.3.1 Astellas Pharma Inc Details

2.3.2 Astellas Pharma Inc Major Business

2.3.3 Astellas Pharma Inc SWOT Analysis

2.3.4 Astellas Pharma Inc Product and Services

2.3.5 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.4 Ncardia

2.4.1 Ncardia Details

2.4.2 Ncardia Major Business

2.4.3 Ncardia SWOT Analysis

2.4.4 Ncardia Product and Services

2.4.5 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.5 Cell Inspire Biotechnology

2.5.1 Cell Inspire Biotechnology Details

2.5.2 Cell Inspire Biotechnology Major Business

2.5.3 Cell Inspire Biotechnology SWOT Analysis

2.5.4 Cell Inspire Biotechnology Product and Services

2.5.5 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.6 Sumitomo Dainippon Pharma

2.6.1 Sumitomo Dainippon Pharma Details

2.6.2 Sumitomo Dainippon Pharma Major Business

2.6.3 Sumitomo Dainippon Pharma Product and Services

2.6.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.7 Pluricell Biotech

2.7.1 Pluricell Biotech Details

2.7.2 Pluricell Biotech Major Business

2.7.3 Pluricell Biotech Product and Services

2.7.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

2.8 Fate Therapeutics, Inc

2.8.1 Fate Therapeutics, Inc Details

2.8.2 Fate Therapeutics, Inc Major Business

2.8.3 Fate Therapeutics, Inc Product and Services

2.8.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Players (2015-2020)

3.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Induced Pluripotent Stem Cells (iPSCs) Players Market Share

3.3.2 Top 10 Induced Pluripotent Stem Cells (iPSCs) Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Countries (2015-2020)

4.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Countries (2015-2026)

4.3 United States Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

4.4 Canada Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

4.5 Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Countries (2015-2020)

5.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Countries (2015-2026)

5.3 Germany Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

5.4 France Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

5.5 UK Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

5.6 Russia Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

5.7 Italy Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2015-2020)

6.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Regions (2015-2026)

6.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

6.4 Japan Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

6.5 Korea Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

6.6 India Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

6.7 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Induced Pluripotent Stem Cells (iPSCs) Market Size by Countries (2015-2020)

7.2 South America Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

7.4 Argentina Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue by Regions (2015-2020)

8.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

8.4 UAE Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

8.5 Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

8.6 South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Type (2015-2025)

9.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020)

9.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2020-2025)

9.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Type (2015-2025)

9.2.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2015-2020)

9.2.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Application (2015-2025)

10.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020)

10.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2020-2025)

10.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size and Forecast by Application (2015-2025)

10.2.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2015-2020)

10.2.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Induced Pluripotent Stem Cells (iPSCs) by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Regions (2015-2020)

Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions (2020-2025)

Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Estimation in Various Scenarios in 2020

Table 10. Fujifilm Holding Corporation (CDI) Corporate Information, Location and Competitors

Table 11. Fujifilm Holding Corporation (CDI) Major Business

Table 12. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 13. Fujifilm Holding Corporation (CDI) SWOT Analysis

Table 14. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 15. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 16. ReproCELL Corporate Information, Location and Competitors

Table 17. ReproCELL Major Business

Table 18. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2018-2019)

Table 19. ReproCELL SWOT Analysis

Table 20. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 21. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 22. Astellas Pharma Inc Corporate Information, Location and Competitors

Table 23. Astellas Pharma Inc Major Business

Table 24. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 25. Astellas Pharma Inc SWOT Analysis

Table 26. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 27. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 28. Ncardia Corporate Information, Location and Competitors

Table 29. Ncardia Major Business

Table 30. Ncardia Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 31. Ncardia SWOT Analysis

Table 32. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 33. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 34. Cell Inspire Biotechnology Corporate Information, Location and Competitors

Table 35. Cell Inspire Biotechnology Major Business

Table 36. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 37. Cell Inspire Biotechnology SWOT Analysis

Table 38. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 39. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 40. Sumitomo Dainippon Pharma Corporate Information, Location and Competitors

Table 41. Sumitomo Dainippon Pharma Major Business

Table 42. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 43. Sumitomo Dainippon Pharma SWOT Analysis

Table 44. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 45. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 46. Pluricell Biotech Corporate Information, Location and Competitors

Table 47. Pluricell Biotech Major Business

Table 48. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 49. Pluricell Biotech SWOT Analysis

Table 50. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 51. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 52. Fate Therapeutics, Inc Corporate Information, Location and Competitors

Table 53. Fate Therapeutics, Inc Major Business

Table 54. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Total Revenue (USD Million) (2017-2018)

Table 55. Fate Therapeutics, Inc SWOT Analysis

Table 56. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product and Solutions

Table 57. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 58. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Players (2015-2020)

Table 59. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players (2015-2020)

Table 60. Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) in China (2015-2020)

Table 61. Key Players Induced Pluripotent Stem Cells (iPSCs) Revenue Share in China (2015-2020)

Table 62. North America Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Countries (2015-2020)

Table 63. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Table 64. North America Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Countries (2020-2026)

Table 65. North America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2020-2026)

Table 66. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Countries (2015-2020)

Table 67. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Table 68. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Countries (2020-2026)

Table 69. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2020-2026)

Table 70. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Countries (2015-2020)

Table 71. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Table 72. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Countries (2020-2026)

Table 73. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2020-2026)

Table 74. South America Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Countries (2015-2020)

Table 75. South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Table 76. South America Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Countries (2020-2026)

Table 77. South America Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2020-2026)

Table 78. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Countries (2015-2020)

Table 79. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2015-2020)

Table 80. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Countries (2020-2026)

Table 81. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Countries (2020-2026)

Table 82. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Type (2015-2020)

Table 83. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type (2015-2020)

Table 84. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Type (2020-2025)

Table 85. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2020-2025)

Table 86. China Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Type (2015-2020)

Table 87. China Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type (2015-2020)

Table 88. China Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Type (2020-2025)

Table 89. China Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2020-2025)

Table 90. Global Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Application (2015-2020)

Table 91. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2015-2020)

Table 92. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Application (2020-2025)

Table 93. Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2020-2025)

Table 94. China Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) by Application (2015-2020)

Table 95. China Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2015-2020)

Table 96. China Induced Pluripotent Stem Cells (iPSCs) Revenue Forecast by Application (2020-2025)

Table 97. China Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2020-2025)

Table 98.List of Figures

Table 99. Induced Pluripotent Stem Cells (iPSCs) Picture

Table 100. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Table 101. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type in 2019

Table 102. Human iPSCs Picture

Table 103. Mouse iPSCs Picture

Table 104. Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application in 2019

Table 105. Academic Research Picture

Table 106. Drug Development and Discovery Picture

Table 107. Toxicity Screening Picture

Table 108. Regenerative Medicine Picture

Table 109. Others Picture

Table 110. Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Growth Rate (2015-2025) (USD Million)

Table 111. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Regions (2015-2025)

Table 112. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Regions in 2019

Table 113. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Regions (2020-2025)

Table 114. North America Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) and Growth Rate (2015-2025)

Table 115. Europe Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) and Growth Rate (2015-2025)

Table 116. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) and Growth Rate (2015-2025)

Table 117. South America Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) and Growth Rate (2015-2025)

Table 118. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Revenue (USD Million) and Growth Rate (2015-2025)

Table 119. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Players in 2019

Table 120. Global Top 5 Players Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share in 2019

Table 121. Top 10 Players Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share in Global Market in 2019

Table 122. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) by Type (2015-2025)

Table 123. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Application (2015-2025)

Table 124. North America Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Countries (2015-2025)

Table 125. North America Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Countries in 2019

Table 126. United States Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 127. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 128. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 129. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Countries (2015-2025)

Table 130. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Countries in 2019

Table 131. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 132. France Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 133. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 134. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 135. Spain Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 136. UK Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 137. Asia Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Countries (2015-2025)

Table 138. Asia Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Countries in 2019

Table 139. China Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 140. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 141. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 142. India Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 143. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 144. South America Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Countries (2015-2025)

Table 145. South America Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Countries in 2019

Table 146. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 147. Argentina Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 148. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Countries (2015-2025)

Table 149. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Countries in 2019

Table 150. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 151. UAE Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 152. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 153. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (USD Million) and Forecast (2015-2025)

Table 154. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type (2015-2020)

Table 155. China Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Type (2015-2020)

Table 156. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2015-2020)

Table 157. China Induced Pluripotent Stem Cells (iPSCs) Revenue Share by Application (2015-2020)

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz